Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
1 study found for:    19922626 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Safety of Daily Dose Esomeprazole for GERD for Pediatric and Adolescent Patients
Condition: Gastroesophageal Reflux Disease (GERD)
Intervention: Drug: Esomeprazole (Nexium)

Study has passed its completion date and status has not been verified in more than two years.